Trial Profile
Efficacy of C.E.R.A for Correction of Anemia and Maintenance of the Hb Levels in CKD Patients in Stage III - IV , Not on Dialysis , Treated According to Routine Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jun 2017
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Expanded access; Therapeutic Use
- Sponsors Roche
- 26 Oct 2016 Status changed from withdrawn prior to enrolment to completed.
- 10 Mar 2014 New trial record